The Week in Review: Oct 19 – Oct 26, 2018

Friday, Oct 26, 2018 News Recap: HepCBC Annual General Meeting INVITATION TO ALL We invite everyone to have a say in the direction of HepCBC, a BC-wide patient advocacy group confronting Viral Hepatitis since 1996, through participation in our upcoming Annual General Meeting (AGM) – either in person or online! 7th Annual Liver Forum 2018 in Vancouver! On October 19th, Volunteers Douglas Laird and Cheryl Reitz of HepCBC attended the exciting 7th ...

Does Pharma Try to Influence Patient Advocacy Groups such as HepCBC?

The Globe and Mail published an article on October 22nd by Kelly Grant entitled, “How pharma firms try to use funding to sway patient advocate groups.” (https://www.theglobeandmail.com/canada/article-how-pharma-companies-try-to-use-funding-to-sway-patient-advocate/). This article, which rightly exposes some of the clear dangers inherent in the relationship between industry funders and patient groups, mentions two of HepCBC's occasional funders, Janssen and

Sky-high price of hepatitis C drug produces profits for lawmakers

While patients in Massachusetts await affordable doses of the blockbuster hepatitis C drug Sovaldi, Rep. Joseph Kennedy III has financially benefited from the success of the drug’s manufacturer, Gilead Sciences, according to public financial disclosures and campaign finance records. And he’s not the only lawmaker profiting from investments in a company that has drawn unwelcome attention for the sky-high price of a lifesaving medication it produces. Kenn...